Lung cancer is the most common cancer in men and women in the world. It is also the leading
cause of cancer death in women. Lung cancer is caused by the spread of cancer cells from the
inside of the lungs to other parts of the body. The most common types of lung cancer are lung
adenocarcinoma and lung squamous cell carcinoma. The most common causes of lung cancer are
smoking, exposure to asbestos, and exposure to radon.
Non-small cell lung cancer
Non-small cell lung cancer histology is a complex topic with many different types of cancer. The
histology of non-small-cell lung cancer is not as well understood as the histology of small-cell
lung cancer. There are many different types of non-small cell lung cancer, and each has a
Non-small cell lung cancer histology can be divided into two main categories: cancer that is
associated with cigarette smoking, and cancer that is not associated with cigarette smoking.
Cancer that is associated with cigarette smoking tends to have more aggressive histology, and it
is more likely to spread to other parts of the body. Cancer that is not associated with cigarette
smoking is less likely to spread, but it may be more difficult to treat.
When it comes to medications, monotherapy is one of the most popular options. This means that a patient will take just one drug to treat their condition. However, monotherapy is not without its risks and side effects. One of the main risks of monotherapy is the potential for drug-resistant infections. When a patient is only taking one medicine, the chances of developing a resistant infection are greater.
This can be especially dangerous if the patient is not taking their medicine as prescribed. Another potential side effect of monotherapy is the development of drug-resistant strains of bacteria. When a patient is only taking one medicine, the bacteria may become resistant to that drug. This can lead to serious health problems if the patient is not treated.
If you are considering monotherapy as your treatment option, it is important to discuss the risks and benefits with your doctor. They will be able to recommend the best medicine for your specific needs.
Did you know the amazing benefits of Afatinib?
Afatinib (pronounced aff-a-tin-ib) is a treatment for cancer, also known by the brand name
Giotrif (pronounced jee-oh-tariff). Afatinib, sold by its brand name, Gilotrif, among others, is a
medicine used for non-small cell lung carcinoma (NSCLC).
Afatinib has received regulatory approval to use as a treatment for NSCLC, though emerging
data supports its use for other tumors, such as breast cancer.
Indications for this medicine-
GIOTRIF as monotherapy is indicated for the treatment of adult patients* with epidermal growth
factor receptor (EGFR)-naive, locally advanced, or metastatic non-small cell lung cancer
(NSCLC) with an activated mutation of EGFR(s); adult patients with locally advanced, or
metastatic, NSCLC with squamous histology who are progressive with platinum-based
chemotherapy or after platinum-based chemotherapy.
There are a number of indications for using afatinib for lung cancer, including:
● Metastatic or locally advanced lung cancer that has not responded to other treatments
● Lung cancer that has progressed despite treatment with platinum-based chemotherapy
and/or radiation therapy
● Lung cancer that has recurred after treatment with platinum-based chemotherapy and/or
● Advanced or metastatic lung cancer
● Lung cancer that has spread to other parts of the body
● Non-Small Cell Lung Cancer that has not responded to other treatments
Your healthcare provider may have suggested Afatinib for conditions other than those listed in these medicine information articles. Be sure to tell your doctor and pharmacist about all of the products you use. Use this medicine regularly to get the most benefit.
Side effects due to this medicine
Certain medicines and supplements may interfere with the way this medicine works, so make sure you tell your healthcare team about all of the doses, vitamins, and supplements that you take. If you take too much Afatinib, talk to your healthcare team or go to the emergency room immediately.
If you get diarrhea when taking Afatinib, it is essential that it is treated right away. Your condition will not get better faster, and the risk of severe side effects increases. Because this medicine can be absorbed through your skin and lungs and can harm your unborn child, women who are pregnant or may become pregnant should not handle this medicine or breathe in dust from tablets.
If your provider finds you have ILD caused by Gilotrif (afatinib), your provider will likely tell you to stop taking Gilotrif (afatinib). Your healthcare provider can modify the dosage, temporarily stop, or permanently stop GILOTRIF if you get some side effects. During your
treatment with GILOTRIF, your healthcare provider should prescribe medicines to treat diarrhea. If you have trouble breathing, your healthcare provider may tell you to stop taking afatinib 30mg tablet while your healthcare provider finds out what is causing those problems. To help you remember, take afatinib at the same time every day. Do not increase the dosage or take this medicine more frequently or longer than prescribed. You generally keep taking Afatinib(pronounced aff-a-tin-ib) for as long as it is still working, unless your side effects become too severe.
There are a few afatinib manufacturers. The most well-known is magicine pharma, which produces afatinib. Other afatinib manufacturers include Novartis, Roche, Eli Lilly, and Astra Zeneca